Hepatic Disorders Flashcards
cirrhosis s/s
portal HTN, ascites, gastro-esophageal varices, splenomegaly (thrombocytopenia), encephalopathy
cirrhosis wu
- high INR & low albumin (dec protein prod)
- high conj bili (dec processing) & eventual inc unconj bili
- US (ascites, portal vein thrombosis)
- Dx para (true ascites (sAlbumin:peritoneal alb of > 1.1) vs SBP)
- liver bx
- EGD (varices screen)
cirrhosis mgmt
- ascites: salt restrict, diuretics, tx para, TIPS if refract, abx for 2ndary inf
- encephalopathy: lactulose (reduce ammonia)
- tx viral if present
- no EtOH
- Hep A, B imm
- transplant (MELD)
prognostic tools
Child-Pugh (1 yr survival rate) and MELD (liver transplant eval)
Hepatitis eti
viral (MC), toxins (EtOH), meds, industrial organic solvents, infection, autoimmune dz, NASH
hepatitis s/s
- acute: malaise, mya/arthralgia, F, N/V/D, HA, anorexia, dark urine, scleral icterus, abd pain, tender hepatomegaly, LAD, splenomegaly
- chronic: malaise, weak, cirrhosis sx if sev
Hep A (source/trans, imm?, acute/chronic?, misc)
- fecal/oral
- yes (exp for travelers, drug users, chronic liver dz)
- acute (RUQ pain, N/V)
- “infectious hep”: comps of fulminant (necrotic) hep, cholestatic hep
Hep B (source/trans, imm?, acute/chronic?, misc)
- blood, parenteral, sex, dialysis, tattoos
- perQ, mucosal, TRANSPLACENTAL
- imm all infants/adolescents/high risk/perinatal pd
- chronic (unless cleared: ususally limited, interferon/INF)
- “serum hep”: chronic inc risk of cirrhosis & HCC
- DNA
Hep C (source/trans, imm?, acute/chronic?, misc)
- blood, parenteral, sex, IVDU, transfusions
- perQ/mucosal
- chronic: silent progression (tx: Harvoni, ribavirin)
- # 1 cz of liver transplant (bx for staging)
Hep D (source/trans, imm?, acute/chronic?, misc)
- blood
- perQ/mucosal
- chronic
- need Hep B to get Hep D
Hep E (source/trans, imm?, acute/chronic?, misc)
- fecal/oral
- imm for Hep B
- acute (b9, self-limited)
- inc sev in preg, rare in US (endemic in India, Mexico, Iraq, N Africa)
HBsAg (-)
Total anti-HBc (-)
anti-HBs (-)
susceptible to infection
HBsAg (-)
Total anti-HBc (+)
anti-HBs (+)
immune due to infection
HBsAg (-)
Total anti-HBc (-)
anti-HBs (+)
immune due to hep B vacc
HBsAg (+)
Total anti-HBc (+)
IgM anti-HBc (+)
anti-HBs (-)
acutely infected
HBsAg (+)
Total anti-HBc (+)
IgM anti-HBc (-)
anti-HBs (-)
chronically infected
HBsAg (-)
Total anti-HBc (+)
anti-HBs (-)
either: recovering from acute inf, distantly immune (low level of anti-HBs), susceptible w/ false + anti-HBc, or chronic inf w/ rare non-detectable HBsAg
B9 liver neoplasms
- Hemangioma (MC, small, asx, incidental)
- hepatic adenoma (assoc w/ long-term estrogen use, can rupture/bleed = resect)
- focal nodular hyperplasia (poss congenital malform, resect)
- hamartoma (malform)
- cysts: simple, infectious, polycystic liver, biliary cystadenoma, Von Meyenburg complex (multiple, small nodular/cystic lesions)
malignant liver neoplasms (RF, WU)
- EtOH, autoimmune hep, viral hep, alpha-1 antitrypsin deficiency, Wilson’s dz (excess copper, Kayser-Fleischer ring of eyes, tx w/ penicillamine)
- elevated AFT indicate malignancy
hepatocellular carcinoma (HCC)
- malignant
- h/o chronic liver dz/cirrhosis (screen high risk q 6 mos w/ US)
- suspect if cirrhotic pt decompensates
- labs nonspecific (trend AFP)
- Dx img shows multiphasic tumor
- Tx: resect, radiofreq ablation, palliative embolization, transplant (MELD)
metastatic dz (liver mets)
MC malignant hepatic neoplasm in Western world